Katarina Luptakova
2023
In 2023, Katarina Luptakova earned a total compensation of $932.2K as Chief Medical Officer at Xilio Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $156,240 |
|---|---|
| Option Awards | $340,253 |
| Salary | $421,667 |
| Other | $14,010 |
| Total | $932,170 |
Luptakova received $421.7K in salary, accounting for 45% of the total pay in 2023.
Luptakova also received $156.2K in non-equity incentive plan, $340.3K in option awards and $14K in other compensation.
Rankings
In 2023, Katarina Luptakova's compensation ranked 1,288th out of 3,006 executives tracked by ExecPay. In other words, Luptakova earned more than 57.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,288 out of 3,006 | 57th |
Division Manufacturing | 768 out of 1,650 | 54th |
Major group Chemicals And Allied Products | 514 out of 918 | 44th |
Industry group Drugs | 502 out of 881 | 43rd |
Industry Pharmaceutical Preparations | 349 out of 637 | 45th |
Source: SEC filing on April 25, 2024.
Luptakova's colleagues
We found three more compensation records of executives who worked with Katarina Luptakova at Xilio Therapeutics in 2023.